Jeena Sikho Lifecare Limited (JSLL) Earnings Call Transcript & Summary

Ladies and gentlemen, welcome to the Jeena Sikho Lifecare Limited H2 FY '25 and FY '25 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Ranvir Singh from Nuvama Wealth and Investment Limited. Thank you, and over to you, sir.

Yes. Thank you, moderator. So on behalf of Jeena Sikho Lifecare Limited, I extend a very warm welcome to all participants on the H2 FY '25 and Full Year FY '25 Financial Results Discussion Call. Today on our call, we have Acharya Manish Grover-ji, Managing Director; and Mr. Nanak Chand, CFO. Before bringing with this call, I would like to give a short disclaimer. This call may contain some of the forward-looking statements, which are completely based upon management's beliefs, opinions, and expectations as of today. These statements are not a guarantee of company's future performance and involve unforeseen risks and uncertainties. With this, I would like to hand over this call to Acharya for his opening remarks. Over to you, sir.

[Foreign Language]

Thank you, Manish sir. Good afternoon, everyone. As mentioned by Manish sir, we have achieved a healthy financial performance during the H2 FY '25 and FY '25. Here, there are these key highlights of H2 FY '25 results. Our revenue grew by 53% on Y-o-Y basis, that is INR 255 crores in H2 FY '25. The EBITDA during the H2 FY '25 grew by 36% Y-o-Y rate INR 65.60 crores, implying the EBITDA margin of 26%. The H2 FY '25 PAT grew by 17% Y-o-Y INR 43.85 crores. Now FY '25 results, the revenue from the operations grew by 45% Y-o-Y to INR 469 crores. Given why the hospital service business, which is grew by 83% Y-o-Y, that is 253.80 crores, while the product sales grew by 16% to INR 215.27 crores. The EBITDA during the FY '25 grew by 34% Y-o-Y to INR 124.88 crores, implying to EBITDA margin, 27%. The FY '25 PAT grew by 31% Y-o-Y to reach INR 90.73 crores. We maintained a healthy balance sheet with the net cash equivalent to INR 26 crores by the end of the FY '25 or FY '25. Our ROE and ROCE stood 39% and 63%, respectively. We spent INR 42 crores CapEx in FY '25. With this, we can open the floor for the question and answers. Thank you.

[Operator Instructions] First question is from the line of Agastya Dave from CAO Capital.

Am I audible?

Yes, sir, please go ahead.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language] margin attributable to increased cost of procurement for some consumables and medicines. [Foreign Language]

[Foreign Language]

Next question is from the line of Abishek from AB Capital.

[Foreign Language]

[Foreign Language]

Okay, sir. Okay, sir. [Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Okay. Okay. [Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Okay, sir. [Foreign Language]

[Foreign Language]

Okay, sir. [Foreign Language]

[Foreign Language]

[Operator Instructions] Next question is from the line of Akshay from AK Investment.

[Foreign Language]

[Foreign Language]

Okay. [Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Naveen Baid from Nuvama Asset Management.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Okay. [Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Prerana Amanna from Equity Research Program.

Congratulations on a great set of numbers. [Foreign Language] We had a target of 25% this year. [Foreign Language] FY '26, can we reach that 25% of PAT margin?

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Pravesh Kothari from Kothari Investment and Infrastructure.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Akshit Agarwal from Akshit Agarwal HUF.

[Foreign Language]

[Foreign Language]

Next question is from the line of Amit Agarwal, an Individual Investor.

Sir, am I audible?

Yes, sir.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Chirag Shah from White Pine Investment Manager.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Nitin Gupta, an individual investor.

Hello, am I audible?

Yes, sir.

Yes, sir.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Vivi Agarwal from FICAM Family Office.

[Foreign Language]

Mr. Agarwal, we're not able to hear you clearly.

Am I audible?

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Keshav Lahoti from HDFC Securities.

[Foreign Language]

[Foreign Language]

Understood. [Foreign Language]

[Foreign Language]

Next question is from the line of Gaurav Didwania from Cor Advisors LLP.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Abhishek from AB Capital.

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Next question is from the line of Shalin Parikh from MYCPE One.

Hello. [Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

[Foreign Language]

Ladies and gentlemen, that was the last question of the day. I now hand the conference over to Mr. Ranvir Singh from Nuvama Wealth and Investment Limited. Over to you, sir.

Thank you, all. Thank you for participation, and thank you, the management. Sir, Acharya-ji, you would like to [Foreign Language]

[Foreign Language]

Moderator, we can close the call now.

Okay, sir. On behalf of Nuvama Wealth & Investment Limited, that concludes this conference. Thank you for joining us, and you may now disconnect your lines.